Faculty of Medicine, Nursing & Midwifery and Health Sciences, University of Notre Dame Australia, Sydney, Australia; Department of Radiology, Duke University, Durham, NC, USA; Department of Medicine, University of Otago Medical School, Dunedin, New Zealand.
PET Clin. 2024 Apr;19(2):125-129. doi: 10.1016/j.cpet.2023.12.013. Epub 2024 Jan 29.
During the last 2 decades, f-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F FDG PET/CT) has transformed the clinical head and neck cancer imaging for patient management and predicting survival outcomes. It is now widely used for staging, radiotherapy planning, posttherapy assessment, and for detecting recurrence in head and neck cancers and is widely included in NCCN and other evidence based clinical practice guidelines. Future Directions would include evaluating the potential value of FAPI PET/CT for head and neck cancers, opportunity to use volumetric and tumor heterogeneity parameters and deploying AI in diagnostic and therapeutic assessments.
在过去的 20 年中,氟-18 脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(18F FDG PET/CT)改变了头颈部癌症的临床影像诊断,有助于患者管理和预测生存结果。目前,它被广泛用于分期、放疗计划、治疗后评估以及头颈部癌症的复发检测,也被纳入 NCCN 和其他循证临床实践指南。未来的方向将包括评估 FAPI PET/CT 对头颈部癌症的潜在价值,以及利用体积和肿瘤异质性参数并将人工智能应用于诊断和治疗评估的机会。